-
Mashup Score: 0
Two peripheral artery disease case examples highlight the utility of Auryon XL, a radial-length laser atherectomy device.
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0BYOOVIZ Phase 3 Study Design and Primary Endpoints - Eyetube - 5 day(s) ago
What can we learn about the safety, efficacy, and biosimilarity of BYOOVIZ (Biogen) from a phase 3 sstudy? Anat Loewenstein, MD, explains to David Brown, MD, how the study was designed; how it met its primary endpoints; and how the study’s outcomes…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4More Physiologic IOP in Cataract Surgery Matters: Here’s Why - 6 day(s) ago
During a recent symposia series, respected cataract surgeons explained the key advantages of performing cataract surgery with more physiologic IOP when using CENTURION® Vision System with ACTIVE SENTRY®.
Source: crstoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 7The Next Wave of Intravascular Lithotripsy: A Panel Interview on Advances in Treating Calcific PAD - Endovascular Today - 6 day(s) ago
Peripheral artery disease (PAD) has no shortage of plaque modification tools. However, as catheter-based tools and techniques have improved, the compl
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
With hospitals struggling to retain staff and value-based care shrinking healthcare revenues, health systems must look to technology resources to become more efficient, without losing sight of patient care or staff support.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1More Physiologic IOP in Cataract Surgery Matters: Here’s Why - 18 day(s) ago
During a recent symposia series, respected cataract surgeons explained the key advantages of performing cataract surgery with more physiologic IOP when using CENTURION® Vision System with ACTIVE SENTRY®.
Source: crstoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0BYOOVIZ® (ranibizumab nuna) and the Age of Biosimilars - Eyetube - 25 day(s) ago
What do retina specialists need to know about biosimilars in general and BYOOVIZ in particular? Sit down with Anat Loewenstein, MD, and David Brown, MD, as they explore this new era in retina.
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Monofocal IOLs: Impact of Optical Design on Range of Vision - 25 day(s) ago
Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page. Despite the significant advancement of presbyopia-correcting IOL technology, monofocal IOLs—which are designed to restore distance vision at a lower cost and are covered by medical insurance—remain the most
Source: crstoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Shockwave Peripheral IVL: Size for Success - Endovascular Today - 27 day(s) ago
Oversizing by 10% for optimal peripheral IVL results.
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0BYOOVIZ® (ranibizumab nuna) and the Age of Biosimilars - Eyetube - 1 month(s) ago
What do retina specialists need to know about biosimilars in general and BYOOVIZ in particular? Sit down with Anat Loewenstein, MD, and David Brown, MD, as they explore this new era in retina.
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
Ankur Lodha, MD, presents two of the first cases performed using AngioDynamics Auryon XL Catheter for the treatment of peripheral artery disease. | #Sponsored by @angiodynamics https://t.co/F1B1n3K3rq